1. ICH S7A: Safety Pharmacology Studies for Human Pharmaceuticals;Anonymous,2000
2. ICH E14: The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non- antiarrhythmic drugs;Anonymous,2005
3. ICH S7B: The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals;Anonymous,2005
4. Review of the statistical analysis of the dog telemetry study;Aylott;Pharmaceutical Statistics,2011
5. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development;Caruso;Journal of Pharmacological and Toxicological Methods,2014